152 related articles for article (PubMed ID: 15850508)
21. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
[TBL] [Abstract][Full Text] [Related]
23. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
[TBL] [Abstract][Full Text] [Related]
24. [Value of delta model for end-stage liver disease in evaluating the prognosis of liver failure patients with hepatitis B virus].
Guo JC; Li CQ; Xun YH; Wang YF; Yu XL; Shi WZ; Shi JP; Lou CQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):48-50. PubMed ID: 22919754
[TBL] [Abstract][Full Text] [Related]
25. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation.
Brandão A; Fuchs SC; Gleisner AL; Marroni C; Zanotelli ML; Cantisani G
Clin Transplant; 2008; 22(5):651-6. PubMed ID: 18549449
[TBL] [Abstract][Full Text] [Related]
26. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
Antaki F; Lukowski A
J Clin Gastroenterol; 2007 Apr; 41(4):412-5. PubMed ID: 17413612
[TBL] [Abstract][Full Text] [Related]
27. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
[TBL] [Abstract][Full Text] [Related]
28. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
[TBL] [Abstract][Full Text] [Related]
29. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
Buenadicha AL; Martín LG; Martín EE; Pajares Ad; Pérez AM; Seral CC; Marugán RB
Transplant Proc; 2005 Nov; 37(9):3881-3. PubMed ID: 16386571
[TBL] [Abstract][Full Text] [Related]
30. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
31. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
[TBL] [Abstract][Full Text] [Related]
32. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of MELD-Na versus MELDNa in the prediction of short-term prognosis for acute-on-chronic hepatitis B liver failure].
He WP; Hu JH; Tong JJ; Liu FF; Wang HF
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1173-7. PubMed ID: 21756769
[TBL] [Abstract][Full Text] [Related]
34. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
[TBL] [Abstract][Full Text] [Related]
35. Indicators and outcome of liver transplantation in acute liver decompensation after flares of hepatitis B.
Lee WC; Chou HS; Wu TJ; Lee CS; Lee CF; Chan KM
J Viral Hepat; 2011 Mar; 18(3):193-9. PubMed ID: 20367797
[TBL] [Abstract][Full Text] [Related]
36. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.
Said A; Williams J; Holden J; Remington P; Gangnon R; Musat A; Lucey MR
J Hepatol; 2004 Jun; 40(6):897-903. PubMed ID: 15158328
[TBL] [Abstract][Full Text] [Related]
37. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis.
Huo TI; Wang YW; Yang YY; Lin HC; Lee PC; Hou MC; Lee FY; Lee SD
Liver Int; 2007 May; 27(4):498-506. PubMed ID: 17403190
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
Chan HL; Chim AM; Lau JT; Hui AY; Wong VW; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
[TBL] [Abstract][Full Text] [Related]
39. Short-term entecavir therapy of chronic severe hepatitis B.
Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
[TBL] [Abstract][Full Text] [Related]
40. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure.
Katoonizadeh A; Decaestecker J; Wilmer A; Aerts R; Verslype C; Vansteenbergen W; Yap P; Fevery J; Roskams T; Pirenne J; Nevens F
Liver Int; 2007 Apr; 27(3):329-34. PubMed ID: 17355453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
